Innoviva (INVA) Accumulated Depreciation & Amortization (2010 - 2013)
Innoviva posted quarterly Accumulated Depreciation & Amortization of $51.8 million for Q4 2013, up 4.83% year-on-year from $49.4 million in Q4 2012, and up 4.83% on a QoQ basis from $49.4 million in Q4 2012.
Innoviva (INVA) has 4 years of Accumulated Depreciation & Amortization data on file, last reported at $51.8 million in Q4 2013.
- For the quarter ending Q4 2013, Accumulated Depreciation & Amortization rose 4.83% year-over-year to $51.8 million; the trailing twelve-month figure through Dec 2013 stood at $51.8 million (up 4.83% YoY), and the FY2013 full-year result was $51.8 million, up 4.83% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2013 stood at $51.8 million, up from $49.4 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $51.8 million in Q4 2013 and bottomed at $43.6 million in Q4 2010.
- The 4-year median for Accumulated Depreciation & Amortization is $48.4 million (2011), against an average of $48.1 million.
- The widest annual swing landed in 2011, when Accumulated Depreciation & Amortization gained 8.58%; it then gained 4.28% in 2012.
- A 4-year view of Accumulated Depreciation & Amortization shows it stood at $43.6 million in 2010, then grew by 8.58% to $47.4 million in 2011, then rose by 4.28% to $49.4 million in 2012, then rose by 4.83% to $51.8 million in 2013.
- The last three Accumulated Depreciation & Amortization figures came in at $51.8 million (Q4 2013), $49.4 million (Q4 2012), and $47.4 million (Q4 2011), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 51.81 Mn |
| Dec 31, 2013 | 51.81 Mn |
| Dec 31, 2012 | 49.42 Mn |
| Dec 31, 2012 | 49.42 Mn |
| Dec 31, 2011 | 47.39 Mn |
| Dec 31, 2011 | 47.39 Mn |
| Dec 31, 2010 | 43.65 Mn |
| Dec 31, 2010 | 43.65 Mn |